Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CT Angiography Shows Gender Differences in Heart Attack Risk

By HospiMedica International staff writers
Posted on 19 Dec 2011
Recent research on coronary computed tomography angiography (CTA), a noninvasive imaging modality used to evaluate the coronary arteries for blockages, reveals different risk scenarios for men and women.

The findings were presented at the scientific assembly and annual meeting of the Radiological Society of North America (RSNA), held November 27-December 2, 2011, in Chicago (IL, USA). More...


Coronary artery disease (CAD) is a narrowing of the blood vessels that supply blood and oxygen to the heart. It is caused by a build-up of fat and other substances that form plaque on vessel walls. According to the US Centers for Disease Control and Prevention (Atlanta, GA, USA), heart disease is the leading cause of death for both men and women in the United States.

Researchers from the Medical University of South Carolina (Charleston, USA; www.musc.edu) analyzed the results of coronary CTA on 480 patients, mean age 55, with acute chest pain. Approximately 65% of the patients were women, and 35% were men. The probability of acute coronary syndrome was ruled out for each of the patients.

Utilizing coronary CTA, the researchers were able to determine the number of vessel segments with plaque, the severity of the blockage and the composition of the plaque. “The latest CT scanners are able to produce images that allow us to determine whether the plaque is calcified, noncalcified, or mixed,” said John W. Nance Jr., MD, currently a radiology resident at Johns Hopkins Hospital (Baltimore, MD, USA).

By comparing the coronary CTA results with outcome data over a 12.8-month follow-up period, the researchers were able to correlate the extent, severity, and type of plaque build-up with the occurrence of major adverse cardiac events, such as a heart attack or coronary bypass surgery. The statistical analysis tested all plaques combined (calcified, noncalcified and mixed) and each individual plaque type separately. “We found that the risks for cardiovascular events associated with plaque were significantly different between women and men,” Dr. Nance said.

Within the follow-up period, 70 of the patients experienced major adverse cardiac events, such as death, heart attack, unstable angina, or revascularization. In total, 87 major adverse cardiac events occurred among the patients during the follow-up period. When outcome data were correlated with the CTA combined plaque findings, the results indicated that women with a large amount of plaque accumulation and extensive atherosclerosis are at significantly greater cardiovascular risk than men.

Specifically, the risk for major adverse cardiac events was considerably higher in women than in men when extensive plaque of any type was present or when more than four artery segments were narrowed. “This research tells us that extensive coronary plaque is more worrisome in women than the equivalent amount in men,” Dr. Nance said.

However, when studying risk factors tied to the presence of individual types of plaque, the risk for major adverse cardiac events was greater in men, compared to women, when their artery segments contained noncalcified plaque.

Dr. Nance reported that the new data suggested that the atherosclerotic process is not necessarily linear and that more research is needed to better understand the disease. “Our research confirms that coronary CTA provides excellent prognostic information that helps identify risk, but there are gender differences that need to be considered.”

Related Links:
Medical University of South Carolina




Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.